What do we know about adenovirus in renal transplantation?

Nephrology Dialysis Transplantation

Volumn 28, Issue 8, 2013, Pages 2003-2010

  Florescu, Marius C ^a   Miles, Clifford D ^a   Florescu, Diana F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Disease; Infection; Kidney transplantation; Renal transplantation

Indexed keywords

CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; PROBENECID; RIBAVIRIN;

ADENOVIRUS INFECTION; ANEMIA; ARTICLE; ASYMPTOMATIC INFECTION; CLINICAL FEATURE; CYSTOSCOPY; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG RESPONSE; DRUG SAFETY; HUMAN; INFECTION RISK; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAPID TEST; RISK FACTOR; TREATMENT OUTCOME; UVEITIS; VIRUS CULTURE; VIRUS DETECTION;

ADENOVIRUS; DISEASE; INFECTION; KIDNEY TRANSPLANTATION; RENAL TRANSPLANTATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANTIVIRAL AGENTS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION;

EID: 84884577076     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft036     Document Type: Article

References (61)

1. Ruuskanen O, Meurman O, Akusjarvi G. Adenoviruses. In: Richman DD, Whitley RJ, Hayden FG ed. Clinical Virology. Washington, DC: ASM Press, 2002, pp. 515-535
2. Echavarria M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 2008; 21: 704-715
3. Hoffman JA. Adenoviral disease in pediatric solid organ transplant recipients. Pediatr Transplant 2006; 10: 17-25
4. Ison MG, Green M. AST Infectious Diseases Community of Practice. Adenovirus in solid organ transplant recipients. Am J Transplant 2009; 9: S161-S165
5. Asim M, Chong-Lopez A, Nickeleit V. Adenovirus infection of a renal allograft. Am J Kidney Dis 2003; 41: 696-701
6. Shiramizu T, Satoh T, Jinushi K et al. Renal allograft dysfunction with acute hemorrhagic cystitis caused by adenovirus in a recipient of a transplanted kidney. Tokai J Exp Clin Med 1986; 11: 371-375
7. Shinohara Y, Hashimoto K, Ikegami M et al. Hemorrhagic kidney graft pyelonephritis caused by type 37 adenovirus infection. Transplant Proc 1992; 24: 1565-1566
8. Garnett CT, Pao CI, Gooding LR. Detection and quantitation of subgroup C adenovirus DNA in human tissue samples by realtime PCR. Methods Mol Med 2007; 130: 193-204
9. Mahr JA, Gooding LR. Immune evasion by adenoviruses. Immunol Rev 1999; 168: 121-130
10. Ljungman P, Ribaud P, Eyrich M et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003; 31: 481-486
11. Suparno C, Milligan DW, Moss PA et al. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma 2004; 45: 873-885
12. Watcharananan SP, Avery R, Ingsathit A et al. Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery. Am J Transplant 2011; 11: 1308-1314
13. McGrath D, Falagas ME, Freeman R et al. Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. J Infect Dis 1998; 177: 459-462
14. Humar A. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Transplantation 2006; 82: S9-S14
15. Liu M, Worley S, Arrigain S et al. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis 2009; 11: 304-312
16. Florescu DF, Islam MK, Mercer DF et al. Adenovirus infections in pediatric small bowel transplant recipients. Transplantation 2010; 90: 198-204
17. Michaels MG, Green M, Wald ER et al. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992; 165: 170-174
18. Hofland CA, Eron LJ, Washecka RM. Hemorrhagic adenovirus cystitis after renal transplantation. Transplant Proc 2004; 36: 3025-3027
19. Hoffman JA, Shah AJ, Ross LA et al. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 388-394
20. Pinchoff RJ, Kaufman SS, Magid MS et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003; 76: 183-189
21. McLaughlin GE, Delis S, Kashimawo L et al. Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR. Am J Transplant 2003; 3: 224-228
22. Humar A, Kumar D, Mazzulli T et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant 2005; 5: 2555-2559
23. Yagisawa T, Takahashi K, Yamaguchi Y et al. Adenovirus induced nephropathy in kidney transplant recipients. Transplant Proc 1989; 21: 2097-2099
24. Koga S, Shindo K, Matsuya F et al. Acute hemorrhagic cystitis caused by adenovirus following renal transplantation: review of the literature. J Urol 1993; 149: 838-839
25. McGilvray ID, Lajoie G, Humar A et al. Polyomavirus infection and acute vascular rejection in a kidney allograft: coincidence or mimicry? Am J Transplant 2003; 3: 501-504
26. Hoffman JA. Adenovirus infections in solid organ transplant recipients. Curr Opin Organ Transplant 2009; 14: 625-633
27. Myerowitz RL, Stalder H, Oxman MN et al. Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med 1975; 59: 591-598
28. Ardehali H, Volmar K, Roberts C et al. Fatal disseminated adenoviral infection in a renal transplant patient. Transplantation 2001; 71: 998-999
29. Rosario RF, Kimbrough RC, Van Buren DH et al. Fatal adenovirus serotype-5 in a deceased-donor renal transplant recipient. Transpl Infect Dis 2006; 8: 54-57
30. Jeulin H, Salmon A, Bordigoni P et al. Comparison of in-house real-time quantitative PCR to the adenovirus R-gene kit for determination of adenovirus load in clinical samples. J Clin Microbiol 2010; 48: 3132-3137
31. Leruez-Ville M, Minard V, Lacaille F et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 2004; 38: 45-52
32. Lankester AC, Heemskerk B, Claas EC et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis 2004; 38: 1521-1525
33. Seidemann K, Heim A, Pfister ED et al. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am J Transplant 2004; 4: 2102-2108
34. Sujeet K, Vasudev B, Desai P et al. Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient. Transpl Infect Dis 2011; 13: 174-177
35. Storsley L, Gibson IW. Adenovirus interstitial nephritis and rejection in an allograft. J Am Soc Nephrol 2011; 22: 1423-1427
36. Varma MC, Kushner YB, Ko DS et al. Early onset adenovirus infection after simultaneous kidney-pancreas transplant. Am J Transplant 2011; 11: 623-627
37. Friedrichs N, Eis-Hubinger AM, Heim A et al. Acute adenoviral infection of a graft by serotype 35 following renal transplantation. Pathol Res Pract 2003; 199: 565-570
38. Lim AK, Parsons S, Ierino F. Adenovirus tubulointerstitial nephritis presenting as a renal allograft space occupying lesion. Am J Transplant 2005; 5: 2062-2066
39. de Mezerville MH, Tellier R, Richardson S et al. Adenoviral infections in pediatric transplant recipients: a hospital-based study. Pediatr Infect Dis J 2006; 25: 815-818
40. Emovon OE, Lin A, Howell DN et al. Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant 2003; 18: 2436-2438
41. Alsaad KO, Tobar A, Belanger E et al. Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft. Nephrol Dial Transplant 2007; 22: 1257-1260
42. Morfin F, Dupuis-Girod S, Mundweiler S et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 2005; 10: 225-229
43. Lenaerts L, Naesens L. Antiviral therapy for adenovirus infections. Antiviral Res 2006; 71: 172-180
44. Green M, Tzakis A, Reyes J et al. Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991; 23: 3038-3039
45. Green M, Ljungman P, Michaels MG. Adenovirus, parvovirus B19, papilloma virus, and polyomaviruses after hemopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV (eds). Transplant Infections. Philadelphia: Lippincott Williams & Wilkins, 2003, pp. 412-438
46. Legrand F, Berrebi D, Houhou N et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001; 27: 621-626
47. Engelmann G, Heim A, Greil J et al. Adenovirus infection and treatment with cidofovir in children after liver transplantation. Pediatr Transplant 2009; 13: 421-428
48. Refaat M, McNamara D, Teuteberg J et al. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant 2008; 27: 699-700
49. Ribaud P, Scieux C, Freymuth F et al. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis 1999; 28: 690-691
50. Doan ML, Mallory GB, Kaplan SL et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant 2007; 26: 883-889
51. Saquib R, Melton LB, Chandrakantan A et al. Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin. Transpl Infect Dis 2010; 12: 77-83
52. Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 2004; 23: 583-588
53. Gilead Sciences, Inc. Vistide®(cidofovir injection). 2000
54. Anderson EJ, Guzman-Cottrill JA, Kletzel M et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant 2008; 12: 219-227
55. Nagafuji K, Aoki K, Henzan H et al. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2004; 34: 909-914
56. Painter W, Robertson A, Trost LC et al. First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against doublestranded DNA viruses. Antimicrob Agents Chemother 2012; 56: 2726-2734
57. Florescu DF, Pergam SA, Neely MN et al. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant 2012; 18: 731-738
58. Mawhorter S, Yamani MH. Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Curr Opin Organ Transplant 2008; 13: 581-585
59. Broeders EN, Wissing KM, Hazzan M et al. Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complications. Transpl Int 2008; 21: 57-64
60. Pollock CA, Mahony JF, Ibels LS et al. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 1989; 47: 952-956
61. Keven K, Sahin M, Kutlay S et al. Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis 2003; 5: 181-186